Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice

Neuroscience Letters

Volumn 532, Issue 1, 2013, Pages 1-6

  Atkins, Coleen M ^a   Cepero, Maria L ^a   Kang, Yuan ^a   Liebl, Daniel J ^a   Dietrich, W Dalton ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclic AMP,Contusion,Controlled cortical impact,Mice,Phosphodiesterase Rolipram

Indexed keywords

EOSIN; HEMATOXYLIN; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN CORTEX; CONTROLLED STUDY; CRANIOTOMY; DENTATE HILUS; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; NOTE; PARIETAL CORTEX; PRIORITY JOURNAL; STAINING; TISSUE SECTION; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; BRAIN INJURIES; CELL DEATH; MALE; MICE; MICE, INBRED C57BL; NEURONS; PHOSPHODIESTERASE 4 INHIBITORS; ROLIPRAM;

EID: 84871035112     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.10.019     Document Type: Note

References (45)

1. Ariga M., Neitzert B., Nakae S., Mottin G., Bertrand C., Pruniaux M.P., Jin S.L., Conti M. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation. Journal of Immunology 2004, 173:7531-7538.
2. Atkins C.M., Kang Y., Furones C., Truettner J.S., Alonso O.F., Dietrich W.D. Postinjury treatment with rolipram increases hemorrhage after traumatic brain injury. Journal of Neuroscience Research 2012, 90:1861-1871.
3. Atkins C.M., Oliva A.A., Alonso O.F., Pearse D.D., Bramlett H.M., Dietrich W.D. Modulation of the cAMP signaling pathway after traumatic brain injury. Experimental Neurology 2007, 208:145-158.
4. Block F., Tondar A., Schmidt W., Schwarz M. Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats. Neuroreport 1997, 8:3829-3832.
5. Chang Y.C., Huang C.C., Hung P.L., Huang H.M. Rolipram, a phosphodiesterase type IV inhibitor, exacerbates periventricular white matter lesions in rat pups. Pediatric Research 2008, 64:234-239.
6. Dixon C.E., Clifton G.L., Lighthall J.W., Yaghmai A.A., Hayes R.L. A controlled cortical impact model of traumatic brain injury in the rat. Journal of Neuroscience Methods 1991, 39:253-262.
7. Fann J.R., Hart T., Schomer K.G. Treatment for depression after traumatic brain injury: a systematic review. Journal of Neurotrauma 2009, 26:2383-2402.
8. Faul M., Xu L., Wald M.M., Coronado V.G. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths, Centers for Disease Control and Prevention 2010, National Center for Injury Prevention and Control Atlanta, GA.
9. Gorman L.K., Shook B.L., Becker D.P. Traumatic brain injury produces impairments in long-term and recent memory. Brain Research 1993, 614:29-36.
10. Gurney M.E., Burgin A.B., Magnusson O.T., Stewart L.J. Small molecule allosteric modulators of phosphodiesterase 4. Handbook of Experimental Pharmacology 2011, 167-192.
11. Helmy A., Antoniades C.A., Guilfoyle M.R., Carpenter K.L., Hutchinson P.J. Principal component analysis of the cytokine and chemokine response to human traumatic brain injury. PLoS One 2012, 7:e39677.
12. Imanishi T., Sawa A., Ichimaru Y., Miyashiro M., Kato S., Yamamoto T., Ueki S. Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents. European Journal of Pharmacology 1997, 321:273-278.
13. Jin S.L., Ding S.L., Lin S.C. Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Chang Gung Medical Journal 2012, 35:197-210.
14. Jin S.L., Lan L., Zoudilova M., Conti M. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. Journal of Immunology 2005, 175:1523-1531.
15. Kato H., Araki T., Itoyama Y., Kogure K. Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil. European Journal of Pharmacology 1995, 272:107-110.
16. Kinoshita K., Chatzipanteli K., Vitarbo E., Truettner J.S., Alonso O.F., Dietrich W.D. Interleukin-1b messenger ribonucleic acid and protein levels after fluid-percussion brain injury in rats: importance of injury severity and brain temperature. Neurosurgery 2002, 51:195-203.
17. Kochanek P.M., Bramlett H., Dietrich W.D., Dixon C.E., Hayes R.L., Povlishock J., Tortella F.C., Wang K.K. A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy. Journal of Trauma 2011, 71:S15-S24.
18. Kochanek P.M., Hendrich K.S., Dixon C.E., Schiding J.K., Williams D.S., Ho C. Cerebral blood flow at one year after controlled cortical impact in rats: assessment by magnetic resonance imaging. Journal of Neurotrauma 2002, 19:1029-1037.
19. Li L.X., Cheng Y.F., Lin H.B., Wang C., Xu J.P., Zhang H.T. Prevention of cerebral ischemia-induced memory deficits by inhibition of phosphodiesterase-4 in rats. Metabolic Brain Disease 2011, 26:37-47.
20. Li Y.F., Cheng Y.F., Huang Y., Conti M., Wilson S.P., O'Donnell J.M., Zhang H.T. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. Journal of Neuroscience 2011, 31:172-183.
21. Lotocki G., de Rivero Vaccari J.P., Perez E.R., Sanchez-Molano J., Furones-Alonso O., Bramlett H.M., Dietrich W.D. Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. Journal of Neurotrauma 2009, 26:1123-1134.
22. Maas A.I., Menon D.K. Traumatic brain injury: rethinking ideas and approaches. The Lancet Neurology 2012, 11:12-13.
23. Marklund N., Hillered L. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?. British Journal of Pharmacology 2011, 164:1207-1229.
24. Matsushita Y., Bramlett H.M., Alonso O., Dietrich W.D. Posttraumatic hypothermia is neuroprotective in a model of traumatic brain injury complicated by a secondary hypoxic insult. Critical Care Medicine 2001, 29:2060-2066.
25. McConeghy K.W., Hatton J., Hughes L., Cook A.M. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS Drugs 2012, 26:613-636.
26. Morganti-Kossmann M.C., Rancan M., Stahel P.F., Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Current Opinion in Critical Care 2002, 8:101-105.
27. Nikulina E., Tidwell J.L., Dai H.N., Bregman B.S., Filbin M.T. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8786-8790.
28. Passineau M.J., Green E.J., Dietrich W.D. Therapeutic effects of environmental enrichment on cognitive function and tissue integrity following severe traumatic brain injury in rats. Experimental Neurology 2001, 168:373-384.
29. Patel A.D., Gerzanich V., Geng Z., Simard J.M. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. Journal of Neuropathology and Experimental Neurology 2010, 69:1177-1190.
30. Pearse D.D., Pereira F.C., Marcillo A.E., Bates M.L., Berrocal Y.A., Filbin M.T., Bunge M.B. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nature Medicine 2004, 10:610-616.
31. Raghupathi R., McIntosh T.K. Pharmacotherapy for traumatic brain injury: a review. Proceedings of the Western Pharmacology Society 1998, 41:241-246.
32. Reneerkens O.A., Rutten K., Steinbusch H.W., Blokland A., Prickaerts J. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl.) 2009, 202:419-443.
33. Reyes-Irisarri E., Sanchez A.J., Garcia-Merino J.A., Mengod G. Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis. Journal of Neuropathology and Experimental Neurology 2007, 66:923-931.
34. Rutten K., Van Donkelaar E.L., Ferrington L., Blokland A., Bollen E., Steinbusch H.W., Kelly P.A., Prickaerts J.H. Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats. Neuropsychopharmacology 2009, 34:1914-1925.
35. Schaal S.M., Garg M.S., Ghosh M., Lovera L., Lopez M., Patel M., Louro J., Patel S., Tuesta L., Chan W.M., Pearse D.D. The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury. PLoS One 2012, 7:e43634.
36. Shah M.K., Kadowitz P.J. Cyclic adenosine monophosphate-dependent vascular responses to purinergic agonists adenosine triphosphate and uridine triphosphate in the anesthetized mouse. Journal of Cardiovascular Pharmacology 2002, 39:142-149.
37. Simard J.M., Kilbourne M., Tsymbalyuk O., Tosun C., Caridi J., Ivanova S., Keledjian K., Bochicchio G., Gerzanich V. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. Journal of Neurotrauma 2009, 26:2257-2267.
38. Statler K.D., Jenkins L.W., Dixon C.E., Clark R.S., Marion D.W., Kochanek P.M. The simple model versus the super model: translating experimental traumatic brain injury research to the bedside. Journal of Neurotrauma 2001, 18:1195-1206.
39. Stein D.M., Lindel A.L., Murdock K.R., Kufera J.A., Menaker J., Scalea T.M. Use of serum biomarkers to predict secondary insults following severe traumatic brain injury. Shock 2012, 37:563-568.
40. Theus M.H., Ricard J., Bethea J.R., Liebl D.J. EphB3 limits the expansion of neural progenitor cells in the subventricular zone by regulating p53 during homeostasis and following traumatic brain injury. Stem Cells 2010, 28:1231-1242.
41. Utagawa A., Bramlett H.M., Daniels L., Lotocki G., Dekaban G.A., Weaver L.C., Dietrich W.D. Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats. Brain Research 2008, 1207:155-163.
42. Vitarbo E.A., Chatzipanteli K., Kinoshita K., Truettner J.S., Alonso O.F., Dietrich W.D. Tumor necrosis factor α expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery 2004, 55:416-424.
43. Zaloshnja E., Miller T., Langlois J.A., Selassie A.W. Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. Journal of Head Trauma Rehabilitation 2008, 23:394-400.
44. Zhang H.T. Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Current Pharmaceutical Design 2009, 15:1688-1698.
45. Zhang J., Snyder R.D., Herman E.H., Knapton A., Honchel R., Miller T., Espandiari P., Goodsaid F.M., Rosenblum I.Y., Hanig J.P., Sistare F.D., Weaver J.L. Histopathology of vascular injury in Sprague-Dawley rats treated with phosphodiesterase IV inhibitor SCH 351591 or SCH 534385. Toxicologic Pathology 2008, 36:827-839.